182 related articles for article (PubMed ID: 9152417)
1. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
Macchi B; Faraoni I; Zhang J; Grelli S; Favalli C; Mastino A; Bonmassar E
J Gen Virol; 1997 May; 78 ( Pt 5)():1007-16. PubMed ID: 9152417
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 3'-azido 3'deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells.
Zhang J; Balestrieri E; Grelli S; Matteucci C; Pagnini V; D'Agostini C; Mastino A; Macchi B
Virus Res; 2001 Oct; 78(1-2):67-78. PubMed ID: 11520581
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
Balestrieri E; Sciortino MT; Mastino A; Macchi B
Antiviral Res; 2005 Dec; 68(3):154-62. PubMed ID: 16271772
[TBL] [Abstract][Full Text] [Related]
4. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate.
Traina-Dorge VL; Martin LN; Lorino R; Winsor EL; Beilke MA
J Infect Dis; 2007 Feb; 195(4):562-71. PubMed ID: 17230416
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines.
Sato Y; Ito K; Moritoyo T; Fujino Y; Masuda K; Yamaguchi K; Mochizuki M; Izumo S; Osame M; Watanabe T
Curr Eye Res; 1997 Aug; 16(8):782-91. PubMed ID: 9255507
[TBL] [Abstract][Full Text] [Related]
6. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
7. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
8. Infection and cellular activation by human T-cell leukemia viruses, types I and II.
Martin TC; Southern PJ
Virology; 1996 Jul; 221(2):375-81. PubMed ID: 8661450
[TBL] [Abstract][Full Text] [Related]
9. In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.
Lal RB; Owen SM; Rudolph DL; Dawson C; Prince H
Virology; 1995 Jul; 210(2):441-7. PubMed ID: 7542419
[TBL] [Abstract][Full Text] [Related]
10. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.
Wang X; Miyake H; Okamoto M; Saito M; Fujisawa J; Tanaka Y; Izumo S; Baba M
Mol Pharmacol; 2002 Jun; 61(6):1359-65. PubMed ID: 12021397
[TBL] [Abstract][Full Text] [Related]
12. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
13. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
[TBL] [Abstract][Full Text] [Related]
14. Transient HTLV-I infection of a human glioma cell line following cell-free exposure.
Graziani G; Faraoni I; Zhang J; Caronti B; Lauro G; Bonmassar E; Macchi B
Virology; 1993 Dec; 197(2):767-9. PubMed ID: 8249298
[TBL] [Abstract][Full Text] [Related]
15. Relationship between anti-Tax antibody responses and cocultivatable virus in HTLV-I-infected rabbits.
Lydy SL; Conner ME; Marriott SJ
Virology; 1998 Oct; 250(1):60-6. PubMed ID: 9770420
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Ye J; Silverman L; Lairmore MD; Green PL
Blood; 2003 Dec; 102(12):3963-9. PubMed ID: 12907436
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
18. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
Chang S; Griesgraber GW; Southern PJ; Wagner CR
J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
[TBL] [Abstract][Full Text] [Related]
20. Class I-unrestricted noncytotoxic anti-HTLV-I activity of CD8(+) T cells.
Moriuchi M; Moriuchi H
Blood; 2000 Sep; 96(5):1994-5. PubMed ID: 10961906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
